title: Transcatheter closure of atrial septal defect with the Figulla(®) ASD Occluder: a comparative study with the Amplatzer(®) Septal Occluder.
abstract: BACKGROUND
  Single-centre experience in transcatheter closure of atrial septal defect (ASD) using the Figulla(®) ASD Occluder (FSO; Occlutech GmbH, Jena, Germany) and the Amplatzer(®) Septal Occluder (ASO; Saint-Jude Medical, Zaventem, Belgium) has been reported.
  
  
  OBJECTIVE
  To perform a retrospective comparison of the two occluders.
  
  
  METHODS
  From September 2009 to December 2012, 131 consecutive patients underwent percutaneous ASD occlusion: One hundred with the ASO device; 31 with the FSO device.
  
  
  RESULTS
  There were no significant differences between the two groups regarding patient characteristics, stretched diameter, age and device size. In the ASO group, implantation succeeded in all but two patients because of deficient rim. Another patient had device embolization in the aorta retrieved percutaneously. During follow-up, 86 patients had no residual shunt and nine patients had a residual shunt (small in seven; moderate in two). Two other patients had persistent interatrial small shunt caused by an adjacent ASD close to the device. In the FSO group, implantation succeeded in all but two patients: one because of deficient posterior rim; and one because of complete atrioventricular block that resolved after device extraction. During follow-up, no shunt was observed in all but one patient. At late follow-up (up to 36months), full occlusion was observed in 88 (88.0%) patients in the ASO group and 28 (90.3%) patients in the FSO group (with no significant difference between groups).
  
  
  CONCLUSIONS
  Transcatheter closure of ASD with the FSO is feasible and safe. FSO results compare favorably with ASO results. However, additional long-term studies that include more patients are mandatory.
authors.affiliation: Université Lille Nord de France, Département de Cardiologie Infantile et Congénitale, Centre Hospitalier Régional et Universitaire de Lille, Faculté de Médecine Lille 2, Lille, France. Electronic address: francois.godart@chru-lille.fr.
authors.forename: François
authors.initials: F
authors.lastname: Godart
authors.affiliation: Université Lille Nord de France, Département de Cardiologie Infantile et Congénitale, Centre Hospitalier Régional et Universitaire de Lille, Faculté de Médecine Lille 2, Lille, France.
authors.forename: Ali
authors.initials: A
authors.lastname: Houeijeh
authors.affiliation: Université Lille Nord de France, Département de Cardiologie Infantile et Congénitale, Centre Hospitalier Régional et Universitaire de Lille, Faculté de Médecine Lille 2, Lille, France.
authors.forename: Morgan
authors.initials: M
authors.lastname: Recher
authors.affiliation: Université Lille Nord de France, Département de Cardiologie Infantile et Congénitale, Centre Hospitalier Régional et Universitaire de Lille, Faculté de Médecine Lille 2, Lille, France.
authors.forename: Charles
authors.initials: C
authors.lastname: Francart
authors.affiliation: Université Lille Nord de France, Département d'Échocardiographie, Département de Physiologie, Centre Hospitalier Régional et Universitaire de Lille, Faculté de Médecine Lille 2, Lille, France.
authors.forename: Anne-Sophie
authors.initials: AS
authors.lastname: Polge
authors.affiliation: Université Lille Nord de France, Département d'Échocardiographie, Département de Physiologie, Centre Hospitalier Régional et Universitaire de Lille, Faculté de Médecine Lille 2, Lille, France.
authors.forename: Marjorie
authors.initials: M
authors.lastname: Richardson
authors.affiliation: Université Lille Nord de France, Département d'Échocardiographie, Département d'Anesthésie et de Réanimation Cardiaque, Centre Hospitalier Régional et Universitaire de Lille, Faculté de Médecine Lille 2, Lille, France.
authors.forename: Marie-Andrée
authors.initials: MA
authors.lastname: Cajot
authors.affiliation: Université Lille Nord de France, Département de Biostatistiques, EA 2694; Centre Hospitalier Régional et Universitaire de Lille, Faculté de Médecine Lille 2, Lille, France.
authors.forename: Alain
authors.initials: A
authors.lastname: Duhamel
mesh_terms: D000293:Adolescent; D000328:Adult; D006328:Cardiac Catheterization / Q000009:adverse effects / Q000295:instrumentation*; D002648:Child; D018618:Echocardiography, Doppler, Color; D005240:Feasibility Studies; D005260:Female; D006344:Heart Septal Defects, Atrial / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008875:Middle Aged; D011474:Prosthesis Design; D012189:Retrospective Studies; D055989:Septal Occluder Device; D016896:Treatment Outcome; D055815:Young Adult
keywords: Amplatzer; Atrial septal defect; Communication interauriculaire; Fermeture percutanée; Figulla; Transcatheter closure